Malta medical device registration timeline
Source-linked clocksMedicines Authority (Medicines Authority) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class I(Self-declaration (no notified body)) MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock | 0 days | 6-9 months | — | Verified |
| Maltese organisation registration, device registration and free-sale certificate — standard service(National registration under S.L. 458.59, processed under the Schedule 5 standard service) This is the national competent-authority clock, not the conformity-assessment clock: Schedule 5 of S.L. 458.46 fixes a standard service of 30 working days from the date of submission of the application and supporting documentation, and the distributor/importer organisation registration, the certificate of free sale and the device registration lines all sit under it | 30 days | 30-60 days | — | Verified |
| National derogation (MDR Art. 59 and 97, IVDR Art. 54 and 92) — application and renewal(Medicines Authority derogation under S.L. 458.46 Schedule 5) Schedule 5 places the note 'Timeline for the processing of an application is within a 90 working day timeframe' at the end of the Derogations group, in the same position as the group-level notes under the Notified Body, Clinical Investigation and Request-for-advice groups, so it governs the two EUR 1,000 initial derogation lines and the EUR 750 renewal alike | 90 working days | 3-6 months | — | Verified |
| Maltese confirmation of risk classification — advisory service(Optional paid Medicines Authority confirmation under S.L. 458.46 Schedule 5) Schedule 5 lists the request form for medical device or in-vitro diagnostic confirmation of risk classification at EUR 1,000 under a note fixing the processing time within a 90 working day timeframe from date of submission of the application and supporting documentation | 90 days | 3-4 months | — | Verified |
Planning steps and estimates; these are not regulator deadlines.
Malta Medical Device Registration Process
Step-by-step Medicines Authority registration process. Total estimated timeline: 6-9 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by Medicines Authority. Appoint a EU Authorized Representative.
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to Medicines Authority including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksMedicines Authority reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
0 daysIn-depth technical assessment of device safety and performance. Medicines Authority may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, Medicines Authority issues Malta market authorization certificate.
- EU Authorized Representative (for non-EU manufacturers)
- Medicines Authority organisation registration of the distributor or importer — initial application, EUR 500 standard service
- A medical device registered person established in Malta and registered with the Medicines Authority (S.L. 458.59 regulation 5(f) and regulation 6(1))
- Details of every device marketed locally entered in the national medical device database kept by the Medicines Authority (S.L. 458.59 regulation 5(g))
- EUDAMED actor registration, with the first four EUDAMED modules mandatory since 28 May 2026
- English and Maltese are both official languages of Malta and the Maltese market is served in English; no separate Maltese-language IFU instrument was located in the medical device subsidiary legislation
- Medical equipment emitting ionizing radiation also needs the Radiation Protection Board authorisation under S.L. 365.15 (Part III and Part XV)
Reviewed 2026-09-16. End-to-end totals remain planning estimates.